Upgrade to SI Premium - Free Trial

BioVie Inc. (BIVI)

1.69 -0.03 (1.74%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/28/25 *Est.)

Latest Headlines

Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV May 29, 2026 9:01 AM - StreetInsider Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 May 27, 2026 8:00 AM - Globe NewsWire BioVie completes enrollment in long COVID treatment trial May 26, 2026 8:01 AM - StreetInsider BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID May 26, 2026 8:00 AM - Globe NewsWire BioVie completes patient visits for Parkinson's drug trial May 18, 2026 8:01 AM - StreetInsider BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease May 18, 2026 8:01 AM - Globe NewsWire Form 10-Q BIOVIE INC. For: Mar 31 May 11, 2026 4:57 PM - SEC Filing BioVie to host virtual event on bezisterim Parkinson's treatment April 27, 2026 8:00 AM - StreetInsider BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 April 27, 2026 8:00 AM - Globe NewsWire RedChip's Biotech Investor Conference Replays Now Available April 20, 2026 8:04 AM - StreetInsider BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting April 14, 2026 8:01 AM - Globe NewsWire RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference April 2, 2026 8:46 AM - StreetInsider Form SCHEDULE 13D BIOVIE INC. Filed by: DO CUONG V March 25, 2026 5:01 PM - SEC Filing BioVie Announces Abstract Accepted for Presentation at AD/PD 2026 March 12, 2026 8:00 AM - Globe NewsWire Full Article List